Recursion Pharmaceuticals, Inc. RXRX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $665.18M-11.8% | $753.92M+13.0% | $667.15M+25.0% | $533.85M+4.8% | $509.16M-15.6% | ||
| $5.51M+20.0% | $4.59M+46.5% | $3.14M+1.0% | $3.11M+1.0% | $3.08M+1.0% | ||
| $11.74M0.0% | $11.74M— | $0— | $0-100% | $2.47M-91.7% | ||
| —— | —— | —— | —— | —— | ||
| $709.56M-12.7% | $812.85M+13.8% | $714.11M+21.6% | $587.16M+0.5% | $584.15M-18.2% | ||
| $95.81M-7.8% | $103.93M-7.0% | $111.71M-6.9% | $120.04M-5.4% | $126.83M-10.1% | ||
| $87.63M+15.6% | $75.78M+19.4% | $63.49M+24.1% | $51.16M+32.6% | $38.57M+44.8% | ||
| $42.82M-5.6% | $45.34M-5.2% | $47.81M-5.0% | $50.32M-5.4% | $53.19M-19.3% | ||
| $160.17M-1.2% | $162.16M+0.1% | $162.04M-1.4% | $164.27M+3.9% | $158.11M+6.2% | ||
| $294.07M-5.1% | $309.9M-3.9% | $322.34M-5.6% | $341.32M+1.6% | $335.79M0.0% | ||
| $18.28M-21.4% | $23.26M-0.2% | $23.31M-2.0% | $23.78M+6.0% | $22.44M+35.4% | ||
| $12.25M-4.0% | $12.75M-13.0% | $14.66M+55.7% | $9.42M-36.3% | $14.78M+67.5% | ||
| $1.34B-9.1% | $1.47B+5.3% | $1.4B+7.5% | $1.3B-0.2% | $1.31B-9.9% | ||
| $71.72M-6.2% | $76.45M-4.4% | $79.95M+17.1% | $68.27M+29.5% | $52.72M+61.0% | ||
| $14.57M-54.2% | $31.77M+32.1% | $24.06M-19.0% | $29.7M+32.3% | $22.46M-72.6% | ||
| $32.79M-12.8% | $37.61M-20.6% | $47.36M+19.3% | $39.69M+0.1% | $39.65M-35.8% | ||
| $9.27M+1.9% | $9.09M+1.9% | $8.92M+1.9% | $8.75M+1.9% | $8.59M— | ||
| $13.09M+3.3% | $12.66M+9.9% | $11.53M-1.8% | $11.73M-1.0% | $11.85M-14.1% | ||
| $114.72M+0.6% | $114.01M+2.5% | $111.2M-11.9% | $126.24M-2.6% | $129.61M+9.1% | ||
| $129.7M-12.2% | $147.71M-4.8% | $155.1M-5.4% | $164.03M+15.5% | $141.98M-24.3% | ||
| $7.18M-24.9% | $9.56M-19.6% | $11.9M-16.2% | $14.2M-13.7% | $16.45M-13.5% | ||
| $42.84M-8.2% | $46.65M-6.8% | $50.03M-6.3% | $53.4M-4.7% | $56.02M-16.7% | ||
| $16.2M-11.7% | $18.34M-10.5% | $20.5M-9.3% | $22.6M-8.1% | $24.6M— | ||
| $16.2M+72.9% | $9.37M-54.3% | $20.5M-9.3% | $22.6M-8.1% | $24.6M— | ||
| $2.03M-2.6% | $2.08M+102% | $1.03M-34.2% | $1.57M-67.3% | $4.79M— | ||
| $314.75M-8.3% | $343.27M-2.6% | $352.58M-8.0% | $383.21M+3.2% | $371.29M-10.3% | ||
| 2B0.0% | 2B0.0% | 2B0.0% | 2B0.0% | 2B+49,999,900% | ||
| $3.19B+0.7% | $3.17B+6.4% | $2.98B+11.2% | $2.68B+5.0% | $2.55B+3.2% | ||
| -$2.19B-5.7% | -$2.08B-5.5% | -$1.97B-9.0% | -$1.81B-10.5% | -$1.63B-14.1% | ||
| $26.66M-27.4% | $36.72M+7.7% | $34.09M— | —— | —— | ||
| $1.02B-9.4% | $1.13B+8.0% | $1.05B+13.9% | $919.15M-1.6% | $933.95M-9.7% | ||
| $1.34B-9.1% | $1.47B+5.3% | $1.4B+7.5% | $1.3B-0.2% | $1.31B-9.9% | ||
| $24.25M-15.1% | $28.57M-2.2% | $29.22M-21.7% | $37.34M+16.6% | $32.02M-16.0% | ||
| $13.59M-44.9% | $24.65M+12.5% | $21.91M+1.4% | $21.61M-53.2% | $46.12M-6.2% | ||
| $13.59M-44.9% | $24.65M+12.5% | $21.91M+1.4% | $21.61M-53.2% | $46.12M-6.2% | ||
| $12.25M-4.0% | $12.75M-13.0% | $14.66M+55.7% | $9.42M-36.3% | $14.78M+67.5% | ||
| $135.55M-1.8% | $138.02M+0.1% | $137.88M-2.0% | $140.65M+6.0% | $132.74M+3.1% | ||
| $135.55M-1.8% | $138.02M+0.1% | $137.88M-2.0% | $140.65M+6.0% | $132.74M+3.1% | ||
| $135.55M-1.8% | $138.02M+0.1% | $137.88M-2.0% | $140.65M+6.0% | $132.74M+3.1% | ||
| $135.55M-1.8% | $138.02M+0.1% | $137.88M-2.0% | $140.65M+6.0% | $132.74M+3.1% | ||
| $381.71M-1.0% | $385.68M0.0% | $385.83M-1.7% | $392.48M+4.8% | $374.36M+3.3% | ||
| $42.82M-5.6% | $45.34M-5.2% | $47.81M-5.0% | $50.32M-5.4% | $53.19M-19.3% | ||
| $957K0.0% | $957K0.0% | $957K— | —— | —— | ||
| $294.07M-5.1% | $309.9M-3.9% | $322.34M-5.6% | $341.32M+1.6% | $335.79M0.0% | ||
| $42.82M-5.6% | $45.34M-5.2% | $47.81M-5.0% | $50.32M-5.4% | $53.19M-19.3% | ||
| $12.25M-4.0% | $12.75M-13.0% | $14.66M+55.7% | $9.42M-36.3% | $14.78M+67.5% | ||
| $42.82M-5.6% | $45.34M-5.2% | $47.81M-5.0% | $50.32M-5.4% | $53.19M-19.3% | ||
| $12.25M-4.0% | $12.75M-13.0% | $14.66M+55.7% | $9.42M-36.3% | $14.78M+67.5% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $14.57M-54.2% | $31.77M+32.1% | $24.06M-19.0% | $29.7M+32.3% | $22.46M-55.8% | ||
| $114.72M+0.6% | $114.01M+2.5% | $111.2M-11.9% | $126.24M-2.6% | $129.61M+9.1% | ||
| $54.21M-22.8% | $70.23M+32.3% | $53.1M-17.4% | $64.28M+13.2% | $56.8M-30.6% | ||
| $54.21M-22.8% | $70.23M+32.3% | $53.1M-17.4% | $64.28M+13.2% | $56.8M-30.6% | ||
| $14.57M-54.2% | $31.77M+32.1% | $24.06M-19.0% | $29.7M+32.3% | $22.46M-55.8% | ||
| $9.27M+1.9% | $9.09M+1.9% | $8.92M+1.9% | $8.75M+1.9% | $8.59M— | ||
| $1.88M+52.2% | $1.23M-37.0% | $1.96M-11.7% | $2.22M— | —— | ||
| $114.72M+0.6% | $114.01M+2.5% | $111.2M-11.9% | $126.24M-2.6% | $129.61M+9.1% | ||
| $7.18M-24.9% | $9.56M-19.6% | $11.9M-16.2% | $14.2M-13.7% | $16.45M— | ||
| $114.72M+0.6% | $114.01M+2.5% | $111.2M-11.9% | $126.24M-2.6% | $129.61M+9.1% | ||
| $88.58M-8.0% | $96.3M-6.4% | $102.87M-7.0% | $110.68M-5.8% | $117.51M-13.0% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 530.6M+0.5% | 528.2M+7.4% | 491.8M+13.6% | 432.8M+6.5% | 406.4M+2.4% | ||
| $5K0.0% | $5K0.0% | $5K+25.0% | $4K0.0% | $4K0.0% | ||
| —— | —— | —— | —— | —— | ||
| $4.21M+56.5% | $2.69M+7.8% | $2.5M-63.7% | $6.87M-10.4% | $7.67M+32.0% | ||
| $7.54M+64.5% | $4.58M-41.6% | $7.84M-23.0% | $10.18M+74.7% | $5.83M+88.3% | ||
| $4.92M+63.8% | $3M0.0% | $3M— | —— | —— | ||
| $1.88M+52.2% | $1.23M-37.0% | $1.96M-11.7% | $2.22M— | —— | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $2B0.0% | $2B0.0% | $2B0.0% | $2B0.0% | $2B0.0% | ||
| $530.63M+0.5% | $528.18M+7.4% | $491.8M+13.6% | $432.83M+6.5% | $406.41M+2.4% | ||
| $530.63M+0.5% | $528.18M+7.4% | $491.8M+13.6% | $432.83M+6.5% | $406.41M+2.4% | ||
| $18.28M-21.4% | $23.26M-0.2% | $23.31M-2.0% | $23.78M+6.0% | $22.44M+35.4% | ||
| $18.69M-7.5% | $20.21M-7.0% | $21.73M-6.5% | $23.24M-6.1% | $24.76M— | ||
| —— | —— | —— | —— | —— | ||
| $87.63M+15.6% | $75.78M+19.4% | $63.49M+24.1% | $51.16M+32.6% | $38.57M+44.8% | ||
| $135.55M-1.8% | $138.02M+0.1% | $137.88M-2.0% | $140.65M+6.0% | $132.74M+3.1% | ||
| $381.71M-1.0% | $385.68M0.0% | $385.83M-1.7% | $392.48M+4.8% | $374.36M+3.3% | ||
| $7.18M-24.9% | $9.56M-19.6% | $11.9M-16.2% | $14.2M-13.7% | $16.45M— | ||
| $9.27M+1.9% | $9.09M+1.9% | $8.92M+1.9% | $8.75M+1.9% | $8.59M— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1.01M+43.7% | $703K-41.7% | $1.21M-21.5% | $1.54M-5.6% | $1.63M+2.4% | ||
| —— | —— | —— | —— | —— | ||
| $12.56M-30.1% | $17.97M+43.2% | $12.55M+16.5% | $10.77M-3.9% | $11.21M-33.0% | ||
| $11.74M0.0% | $11.74M— | $0— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Recursion Pharmaceuticals, Inc.'s total assets?
- Recursion Pharmaceuticals, Inc. (RXRX) holds $1.3B in total assets, up 2.6% year over year.
- How much debt does Recursion Pharmaceuticals, Inc. have?
- Recursion Pharmaceuticals, Inc. carries $88.6M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does Recursion Pharmaceuticals, Inc. have?
- Recursion Pharmaceuticals, Inc. holds $665.2M in cash and equivalents.
- Can Recursion Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 5.47 — current assets exceed current liabilities.
- Where does Recursion Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Recursion Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
